Richard J. Battafarano

About

Dr. Richard J. Battafarano is a leading thoracic surgeon whose research focuses on advancing surgical techniques and multimodal therapies for lung cancer. He is best known for his pivotal work in neoadjuvant immunotherapy, demonstrated by his highly cited 2018 study (299 citations) on pulmonary resection following nivolumab in resectable non-small cell lung cancer. This landmark research helped establish the safety and feasibility of combining immunotherapy with surgery, shaping modern treatment protocols. Dr. Battafarano has also been instrumental in evaluating minimally invasive approaches, notably comparing robotic-assisted surgery to video-assisted thoracoscopic surgery (VATS) for lung cancer resection. His 2016 study (54 citations) provided early evidence on the outcomes of a new robotic program, contributing to the growing adoption of robotic techniques in thoracic oncology. Through these contributions, Dr. Battafarano has significantly impacted both the surgical management and perioperative care of lung cancer patients, bridging innovation in immunotherapy and minimally invasive surgery to improve patient outcomes.

Research Focus

Key Achievements

Top Papers

1. 1
   Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer

   299 citations · 2018
2. 2
   Robotic Versus Thoracoscopic Resection for Lung Cancer: Early Results of a New Robotic Program

   54 citations · 2016

Key Collaborators

Contact & Links